HCA
CLB icon

Harbor Capital Advisors’s Core Laboratories CLB Stock Holding History

Harbor Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6K Sell
483
-26
-5% -$371 ﹤0.01% 1088
2026
Q1 		$9K Buy
+509
New +$9.11K ﹤0.01% 1003

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Harbor Capital Advisors's CLB Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Core Laboratories (CLB) stake by 5.1% in Q2 2026, selling an estimated $371 and leaving 483 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Harbor Capital Advisors first reported a position in CLB in Q1 2026 and has held it in 2 quarters since. The position peaked at $9K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Harbor Capital Advisors held 483 shares of Core Laboratories worth $6K as of Q2 2026.
  • Harbor Capital Advisors sold 26 Core Laboratories shares in Q2 2026, an estimated $371.
  • Core Laboratories made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #1088 holding.
  • Harbor Capital Advisors first reported a position in Core Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Harbor Capital Advisors's Core Laboratories position peaked at $9K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.